Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Bionano Genomics Inc (NQ: BNGO )

6.870 -0.420 (-5.76%)
Streaming Delayed Price Updated: 12:17 PM EDT, Apr 12, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Bionano Genomics Inc

< Previous 1 2 3 4 5 Next >
Bionano Genomics Announces “At-The-Market” Equity Program
From GlobeNewswire News Releases
Bionano Genomics Reports Second Quarter 2020 Financial Results and Provides Business Update
Company to host conference call today, Thursday, August 13, at 4:30 pm ET 
From GlobeNewswire News Releases
Bionano Featured at Cancer Genomics Consortium Annual Meeting with Multiple Data Readouts that Further Validate Saphyr in the Field of Cytogenetics and Lay Groundwork for a Novel LDT in Cancer
From GlobeNewswire News Releases
Thinking about buying stock in BioNano Genomics, Conduent Inc, OpGen Inc, Uber Technologies, or MGM Resorts?
InvestorsObserver issues critical PriceWatch Alerts for BNGO, CNDT, OPGN, UBER, and MGM. 
From PR Newswire
Bionano Genomics to Report Second Quarter 2020 Financial Results and Host a Conference Call and Webcast on August 13
From GlobeNewswire News Releases
Studies on COVID-19 Disease Susceptibility in China Using Bionano Genomics’ Saphyr Are Progressing and Generating High Quality Data
Samples collected from COVID-19 patients from initial outbreaks in China were analyzed successfully 
From GlobeNewswire News Releases
Metastatic Lung Cancer Study Finds That Bionano’s Saphyr Outperforms NGS for the Detection of Structural Variants
From GlobeNewswire News Releases
Bionano Genome Imaging Provides Essential Scaffolding Results in High Profile Bat Genome Study
Six reference-quality bat genomes described in a publication in Nature reveal how bats can carry and yet survive deadly viruses 
From GlobeNewswire News Releases
Thinking about buying stock in Arbutus Biopharma, Polarityte Inc, Milestone Pharmaceuticals, Vonage, or BioNano Genomics?
InvestorsObserver issues critical PriceWatch Alerts for ABUS, PTE, MIST, VG, and BNGO. 
From PR Newswire
The COVID-19 Host Genome Structural Variant Consortium Formed by Dr. Ravindra Kolhe at Augusta University Creates a Massive Expansion in the Scope of COVID-19 Susceptibility Research with Bionano Geno
From GlobeNewswire News Releases
Bionano Genome Imaging Identifies the Most Common Structural Variations Between Individuals with DiGeorge Syndrome
From GlobeNewswire News Releases
Thinking about buying stock in BioNano Genomics, Actinium Pharmaceuticals, General Electric, Delta Air Lines, or TOP Ships?
InvestorsObserver issues critical PriceWatch Alerts for BNGO, ATNM, GE, DAL, and TOPS. 
From PR Newswire
First Publication from International Consortium Using Bionano Imaging in Genetic Disease Patients Demonstrates that Bionano’s Saphyr Detects All 100 Chromosomal Aberrations in 85 Samples
From GlobeNewswire News Releases
Thinking about buying stock in Nio Inc, Delta Air Lines, Houghton Mifflin Harcourt, Royal Caribbean Cruises, or BioNano Genomics?
InvestorsObserver issues critical PriceWatch Alerts for NIO, DAL, HMHC, RCL, and BNGO. 
From PR Newswire
Bionano Genomics Data is Essential Part of the First Ever Complete Assembly of a Human X-Chromosome
Bionano’s Saphyr data was considered the gold standard for structural accuracy used to correct structural errors in the assembly 
From GlobeNewswire News Releases
Bionano Genomics Solidifies its Entry into Solid Tumor Analysis with Launch of New Kit and Protocol that Significantly Simplify Tissue and Solid Tumor Analysis
Bionano’s new Bionano Prep™ SP Tissue and Tumor Kit enables routine analysis of cancer biopsies and animal tissue expanding its addressable market to include solid tumors and model genomes commonly... 
From GlobeNewswire News Releases
First Extensive Validation Study of Saphyr for Constitutional Genetic Disorders by European Consortium Shows 100% Concordance to Standard Cytogenetics and Describes Resolution of Cases of Long-Standin
From GlobeNewswire News Releases
The UK NHS, the Medical College of Wisconsin, and the Leading South Korean Yonsei University Hospital are Among Newest Adopters of Bionano Saphyr® for Digital Cytogenetic Applications
Represents continued growth of the installed base of Saphyr systems for its use in resolving complex genetic disease cases and simplifying cytogenetic workflows across the world 
From GlobeNewswire News Releases
Bionano Genomics Reports First Quarter 2020 Financial Results and Provides Business Update
Company to host conference call today, Thursday, June 18, at 4:30 pm ET 
From GlobeNewswire News Releases
Bionano Announces Amendment to Proxy Statement for Annual Meeting of Stockholders
Amendment Extends Deadline for Board to Effect or Abandon Reverse Split Amendment 
From GlobeNewswire News Releases
Bionano Genomics to Report First Quarter 2020 Financial Results and Host a Conference Call and Webcast on June 18
From GlobeNewswire News Releases
Data Presented at European Society of Human Genetics (ESHG) Conference Shows Saphyr System has 100% Concordance with Standard Cytogenetics in Leukemias and Constitutional Aberrations
From GlobeNewswire News Releases
Bionano Genomics Announces Issuance of US Patent for Combined Nanochannel-Nanopore Device
From GlobeNewswire News Releases
Bionano to Participate in Maxim Group’s Covid-19 Virtual Conference Series: The Role of Cell Therapy and Clarity on Testing
From GlobeNewswire News Releases
Cancer Genomics Consortium Members Demonstrate 100% Concordance Between Bionano Saphyr and Gold Standard Cytogenetics in Leukemia
Saphyr identifies all variants detected by the standard of care in cytogenetics in over 100 leukemia samples 
From GlobeNewswire News Releases
Bionano Genomics to Report First Quarter 2020 Financial Results on June 18, 2020
From GlobeNewswire News Releases
Bionano Genomics Adds Healthcare and Genomics Industry Experts with Experience in Commercialization and Reimbursement to Its Board of Directors
Appointments add proven business leadership with strategic knowledge of commercialization of diagnostics to support Bionano’s mission of developing solutions in digital cytogenetics and genomics... 
From GlobeNewswire News Releases
Largest North American Site for FSHD Muscular Dystrophy Testing Adopts Bionano Genomics’ Saphyr for Majority of Clinical Tests
University of Iowa to use Bionano-based assay to replace most “gold standard” Southern blot tests for molecular diagnosis of FSHD 
From GlobeNewswire News Releases
NetworkNewsBreaks – Bionano Genomics, Inc. (NASDAQ: BNGO) Closes $18M Follow-On
From InvestorBrandNetwork
BIONANO GENOMICS ANNOUNCES PRICING OF $18 MILLION UNDERWRITTEN PUBLIC OFFERING
From GlobeNewswire News Releases
< Previous 1 2 3 4 5 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.